Dan R. Robinson

Active 1994–2025

62
Papers
30,294
Citations
49
h-index
59
i10-index

Citations

Citations per year for Dan R. Robinson1996: 2 citations1997: 4 citations1998: 6 citations1999: 23 citations2000: 31 citations2001: 48 citations2002: 47 citations2003: 46 citations2004: 35 citations2005: 41 citations2006: 31 citations2007: 30 citations2008: 25 citations2009: 24 citations2010: 22 citations2011: 25 citations2012: 66 citations2013: 180 citations2014: 187 citations2015: 300 citations2016: 475 citations2017: 526 citations2018: 624 citations2019: 1,623 citations2020: 1,828 citations2021: 1,787 citations2022: 1,259 citations2023: 821 citations2024: 1,244 citations2025: 481 citations2026: 10 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,353 citing papers, 28.5% of this breakdownChina: 2,432 citing papers, 15.9% of this breakdownUnited Kingdom: 976 citing papers, 6.4% of this breakdownCanada: 675 citing papers, 4.4% of this breakdownItaly: 650 citing papers, 4.3% of this breakdownGermany: 617 citing papers, 4% of this breakdownFrance: 464 citing papers, 3% of this breakdownAustralia: 435 citing papers, 2.9% of this breakdownSpain: 425 citing papers, 2.8% of this breakdownJapan: 355 citing papers, 2.3% of this breakdownSwitzerland: 323 citing papers, 2.1% of this breakdownNetherlands: 303 citing papers, 2% of this breakdown
0%28.5%Other 21.4%

Fields

  • Biochemistry, Genetics and Molecular Biology50.8%
  • Medicine44.2%
  • Immunology and Microbiology2.1%
  • Agricultural and Biological Sciences0.7%
  • Computer Science0.5%
  • Neuroscience0.5%
  • Other1.2%

Topics

  • Prostate Cancer Treatment and Research8.3%
  • Cancer-related molecular mechanisms research6.8%
  • Cancer Genomics and Diagnostics4.4%
  • Circular RNAs in diseases4.1%
  • RNA modifications and cancer3.9%
  • MicroRNA in disease regulation3.2%
  • Other69.3%

Coauthors

All papers

Open in search
  1. Integrative Clinical Genomics of Advanced Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 cited by 3,701

  2. Genomic correlates of clinical outcome in advanced prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bruce Montgomery, Himisha Beltran, Elisabeth I. Heath, Howard I. Scher, Philip W. Kantoff, Mary‐Ellen Taplin, Nikolaus Schultz, Johann S. de Bono, Francesca Demichelis, Peter S. Nelson, Mark A. Rubin, Arul M. Chinnaiyan, Charles L. Sawyers - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 1,408

  3. The Landscape of Circular RNA in Cancer

    Authors: , , , , , , , , , , , , - Cell 2019 cited by 2,065

  4. The landscape of long noncoding RNAs in the human transcriptome

    Authors: , , , , , , , , , , , , , , , , , , - Nature Genetics 2015 cited by 2,890

  5. The mutational landscape of lethal castration-resistant prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2012 cited by 2,607

  6. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Liying Zhang, Ahmet Zehir, Joseph Vijai, Howard I. Scher, Charles L. Sawyers, Nikolaus Schultz, Philip W. Kantoff, David B. Solit, Mark E. Robson, Eliezer M. Van Allen, Kenneth Offit, Johann S. de Bono, Peter S. Nelson - New England Journal of Medicine 2016 cited by 1,663

  7. DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bernardette Ebbs, Gemma Fowler, Desamparados Roda, Wei Yuan, Yi‐Mi Wu, Xuhong Cao, Rachel Brough, Helen N. Pemberton, Roger A’Hern, Amanda Swain, Lakshmi P. Kunju, Rosalind A. Eeles, Gerhardt Attard, Christopher J. Lord, Alan Ashworth, Mark A. Rubin, Karen E. Knudsen, Felix Y. Feng, Arul M. Chinnaiyan, Emma Hall, Johann S. de Bono - New England Journal of Medicine 2015 cited by 2,187

  8. The long tail of oncogenic drivers in prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wassim Abida, Barry S. Taylor, Howard I. Scher, Peter S. Nelson, Johann S. de Bono, Mark A. Rubin, Charles L. Sawyers, Arul M. Chinnaiyan, Nikolaus Schultz, Eliezer M. Van Allen - Nature Genetics 2018 cited by 884

  9. Integrative clinical genomics of metastatic cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Moshe Talpaz, Marcin Cieslik, Arul M. Chinnaiyan - Nature, Nat. 2017 cited by 938

  10. Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , - Cell 2018 cited by 609

  11. Activating ESR1 mutations in hormone-resistant metastatic breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2013 cited by 1,158

  12. Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer

    Authors: , , , , , , , , , , , , , , , , - Nature 2019 cited by 298

  13. The protein tyrosine kinase family of the human genome

    Authors: , , - Oncogene 2000 cited by 1,152

  14. Integrative Clinical Genomics of Advanced Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Andrea Sboner, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 cited by 591

  15. Identification of Targetable FGFR Gene Fusions in Diverse Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2013 cited by 738

  16. Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emma Hall, Arul M. Chinnaiyan, Suzanne Carreira, Johann S. de Bono - Cancer Discovery 2017 cited by 422

  17. Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2013 cited by 819

  18. Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2021 cited by 159

  19. Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael T. Schweizer, Colin C. Pritchard, Stephen J. Salipante, Mary‐Ellen Taplin, Himisha Beltran, Mark A. Rubin, Marcin Cieślik, Dan R. Robinson, E. Heath, Nikolaus Schultz, Joshua Armenia, Wassim Abida, Howard I. Scher, Christopher J. Lord, Alan D. D’Andrea, Charles L. Sawyers, Arul M. Chinnaiyan, Andrea Alimonti, Peter S. Nelson, Charles G. Drake, Eliezer M. Van Allen, Johann S. de Bono - Journal of Clinical Investigation 2018 cited by 209

  20. Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Valerie P. Castle, Raymond J. Hutchinson, Moshe Talpaz, Dan R. Robinson, Arul M. Chinnaiyan - JAMA 2015 cited by 416

  21. The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Saad Z. Usmani, Ravi Vij, Jeffrey L. Wolf, Jeffrey A. Zonder, P. Leif Bergsagel, Daniel Auclair, Hearn Jay Cho, Dan R. Robinson, Arul M. Chinnaiyan - Nature Communications 2022 cited by 91

  22. Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2023 cited by 34

  23. Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2024 cited by 31

  24. A Randomized Phase II Study of Androgen Deprivation Therapy with or without Palbociclib in RB-positive Metastatic Hormone-Sensitive Prostate Cancer

    Authors: , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 cited by 59